{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:49:35Z","timestamp":1782960575686,"version":"3.54.5"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Ongoing research contributes to our understanding of the epidemiology of vasculitis and its outcomes across the globe. This review aims to summarize important research studies published on this topic in the last 18\u200amonths.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The implementation of rapid referral systems and use of large vessel imaging have improved the diagnosis of giant cell arteritis. A population-based study in immunoglobulin G4-related disease provides incidence and prevalence estimates for the United States for the first time. Recently published data supported viral infectious triggers for Kawasaki disease and immunoglobulin A vasculitis. Population studies in antineutrophil cytoplasmic antibody associated vasculitis report an increase in the incidence of eosinophilic granulomatosis with polyangiitis and have provided further insights into the burden of cardiovascular disease in these patients. Data on Beh\u00e7et's disease continues to show increased all-cause mortality and need for better treatment strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Recent literature highlights the heterogeneity of the epidemiology of vasculitis in different parts of the world as well as associated outcomes, comorbidities, and potential triggers. Thought new classification criteria are being employed in some forms of vasculitis, standardization of case identification remains an unmet need in multiple other forms of vasculitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001073","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:00:45Z","timestamp":1733479245000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology of systemic vasculitis"],"prefix":"10.1097","author":[{"given":"Mehmet","family":"Hocaoglu","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Jaros","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha B.","family":"Dua","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E.","family":"Sattui","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"R1-20241206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20241206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R3-20241206","doi-asserted-by":"crossref","first-page":"e003824","DOI":"10.1136\/rmdopen-2023-003824","article-title":"Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register","volume":"10","author":"Fernandez-Lozano","year":"2024","journal-title":"RMD Open"},{"key":"R4-20241206","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R5-20241206","doi-asserted-by":"crossref","first-page":"1296393","DOI":"10.3389\/fmed.2023.1296393","article-title":"Giant cell arteritis: incidence and phenotypic distribution in Western Norway","volume":"10","author":"Skaug","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R6-20241206","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/art.42325","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"74","author":"Ponte","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R7-20241206","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard-2023-224191","article-title":"Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020","volume":"82","author":"Mukhtyar","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R8-20241206","doi-asserted-by":"crossref","first-page":"rkad071","DOI":"10.1093\/rap\/rkad071","article-title":"Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?","volume":"7","author":"Gisslander","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"R9-20241206","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20241206","first-page":"3208","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: is vascular imaging really ready to determine steroid dosing?","volume":"63","author":"Owen","year":"2024","journal-title":"Rheumatology"},{"key":"R11-20241206","doi-asserted-by":"crossref","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica: a systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R12-20241206","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"De Miguel","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20241206","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R14-20241206","first-page":"3331","article-title":"Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study","volume":"63","author":"Moreel","year":"2024","journal-title":"Rheumatology"},{"key":"R15-20241206","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1093\/rheumatology\/keab406","article-title":"A systematic review and meta-analysis of the incidence rate of Takayasu arteritis","volume":"60","author":"Rutter","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20241206","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R17-20241206","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/ard-2022-223482","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R18-20241206","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R19-20241206","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamapediatrics.2022.3756","article-title":"Incidence of Kawasaki disease before and after the COVID-19 pandemic in japan: results of the 26th Nationwide Survey, 2019 to 2020","volume":"176","author":"Ae","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R20-20241206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/INF.0000000000004095","article-title":"Kawasaki disease before and during the COVID-19 pandemic: a nationwide population-based study in the United States","volume":"43","author":"Sakai-Bizmark","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20241206","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/INF.0000000000004434","article-title":"Declining incidence of Kawasaki disease during the COVID-19 pandemic: a time series analysis","volume":"43","author":"Lin","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20241206","doi-asserted-by":"crossref","first-page":"1307931","DOI":"10.3389\/fped.2024.1307931","article-title":"Decreased incidence of Kawasaki disease in South Korea during the SARS-CoV-2 pandemic","volume":"12","author":"Oh","year":"2024","journal-title":"Front Pediatr"},{"key":"R23-20241206","first-page":"A10220600","article-title":"Changes in Kawasaki disease incidence and phenotype during the COVID-19 pandemic","volume":"70","author":"Unlu","year":"2023","journal-title":"Dan Med J"},{"key":"R24-20241206","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jmii.2024.07.001","article-title":"Respiratory viral infections and Kawasaki disease: a molecular epidemiological analysis","volume":"57","author":"Marutani","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"R25-20241206","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1038\/s41598-024-60830-z","article-title":"Association between maternal heavy metal exposure and Kawasaki Disease, the Japan Environment and Children's Study (JECS)","volume":"14","author":"Yanai","year":"2024","journal-title":"Sci Rep"},{"key":"R26-20241206","doi-asserted-by":"crossref","first-page":"14617","DOI":"10.1038\/s41598-021-93089-9","article-title":"Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model","volume":"11","author":"Low","year":"2021","journal-title":"Sci Rep"},{"key":"R27-20241206","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R28-20241206","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/mr\/roae010","article-title":"Nationwide epidemiological survey of polyarteritis nodosa in Japan in 2020","volume":"34","author":"Kawazoe","year":"2024","journal-title":"Mod Rheumatol"},{"key":"R29-20241206","first-page":"1078","article-title":"International study group for Behcet's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R30-20241206","first-page":"1991","article-title":"Epidemiology and clinical domains of Behcet's disease in the Cantabria region, Northern Spain","volume":"41","author":"Suarez-Amorin","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R31-20241206","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/bjd\/ljae051","article-title":"All-cause and cause-specific mortality in patients with Behcet disease versus the general population","volume":"190","author":"Choi","year":"2024","journal-title":"Br J Dermatol"},{"key":"R32-20241206","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R33-20241206","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/acr2.11405","article-title":"Derivation and validation of algorithms to identify patients with immunoglobulin-G4-related disease using administrative claims data","volume":"4","author":"Wallace","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"R34-20241206","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R35-20241206","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3390\/jcm11092573","article-title":"Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis","volume":"11","author":"Redondo-Rodriguez","year":"2022","journal-title":"J Clin Med"},{"key":"R36-20241206","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R37-20241206","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R38-20241206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 89)","key":"R40-20241206","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-Gomez","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R41-20241206","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/rheumatology\/kez597","article-title":"Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway","volume":"59","author":"Nilsen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R42-20241206","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R43-20241206","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/rheumatology\/kead557","article-title":"Prevalence of antineutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method","volume":"63","author":"Rubenstein","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R44-20241206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1475-097X.1990.tb00090.x","article-title":"Postexercise platelet activation--aggregation and release in relation to dynamic exercise","volume":"10","author":"Naesh","year":"1990","journal-title":"Clin Physiol"},{"key":"R45-20241206","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1183\/23120541.00430-2023","article-title":"Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK","volume":"10","author":"Hwee","year":"2024","journal-title":"ERJ Open Res"},{"key":"R46-20241206","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4168\/aair.2024.16.2.168","article-title":"Incidence, prevalence, and mortality of eosinophilic granulomatosis with polyangiitis in korea: a nationwide population-based study","volume":"16","author":"Lee","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"R47-20241206","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/mr\/road104","article-title":"Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis","volume":"34","author":"Sada","year":"2024","journal-title":"Mod Rheumatol"},{"key":"R48-20241206","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3899\/jrheum.220851","article-title":"Traditional and disease-specific risk factors for cardiovascular events in antineutrophil cytoplasmic antibody-associated vasculitis: a multinational retrospective study","volume":"50","author":"Moiseev","year":"2023","journal-title":"J Rheumatol"},{"key":"R49-20241206","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/kead377","article-title":"Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study","volume":"63","author":"Nygaard","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R50-20241206","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00296-023-05387-2","article-title":"New insights into epidemiological data and impact of the COVID-19 pandemic on IgA vasculitis in children and adults: a French nationwide cohort","volume":"43","author":"Maisons","year":"2023","journal-title":"Rheumatol Int"},{"key":"R51-20241206","doi-asserted-by":"crossref","first-page":"e245362","DOI":"10.1001\/jamanetworkopen.2024.5362","article-title":"Common seasonal pathogens and epidemiology of Henoch-Schonlein purpura among children","volume":"7","author":"Felix","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R52-20241206","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/jcm13051290","article-title":"An investigation of the relationship between Henoch-Schonlein purpura and viral infection in Korea using the health insurance database","volume":"13","author":"Park","year":"2024","journal-title":"J Clin Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:00:58Z","timestamp":1733479258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001073","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}